Nitrocine (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitrocine, is a nitrate vasodilator presented as an intravenous solution for intravenous use. It is employed to relieve acute angina, manage myocardial infarction adjunctively, treat acute heart failure, and address hypertensive emergencies in adult patients.

GNH USA supplies Nitrocine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide with reliable quality and regulatory compliance. The company adheres to EU GMP standards and provides full documentation for import and distribution.

Nitrocine (glyceryl trinitrate) acts as a nitrate vasodilator to relieve myocardial ischemia and lower vascular resistance.

- Acute angina pectoris: rapid relief of chest pain by dilating coronary arteries. - Myocardial infarction (adjunct therapy): improves coronary blood flow during acute infarction. - Acute heart failure: reduces preload and afterload to support cardiac output. - Hypertensive emergencies: provides prompt vasodilation to lower severe blood pressure.

Nitrocine may cause a range of adverse reactions, most of which are related to its vasodilatory action.

Common Side Effects: - Headache: throbbing pain due to cerebral vasodilation. - Flushing: warmth and redness of the skin. - Hypotension: drop in blood pressure, especially with rapid infusion. - Tachycardia: compensatory increase in heart rate. - Dizziness or light‑headedness. - Nausea.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Paradoxical myocardial ischemia. - Methemoglobinemia. - Anaphylactoid or allergic reactions. - Persistent tachyarrhythmias. - Acute renal impairment in susceptible patients.

When using Nitrocine, clinicians should observe specific safety measures.

- Cardiovascular monitoring: observe blood pressure and heart rate during infusion. - Concomitant phosphodiesterase‑5 inhibitors: avoid due to risk of profound hypotension. - Severe anemia or increased intracranial pressure: use with caution. - Known hypersensitivity to nitrates: contraindicated. - Pregnancy and lactation: assess risk–benefit; limited data available. - Store below 25°C: keep in original container, protect from light and moisture.

Nitrocine interacts with several drug classes that can modify its hemodynamic effects.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe hypotension. - Other nitrates or nitrites: additive vasodilatory effect leading to dangerous blood pressure fall. - Potent antihypertensives (e.g., clonidine): risk of excessive hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory tachycardia. - Calcium‑channel blockers: additive blood pressure reduction. - Diuretics: may enhance volume depletion and hypotension. - ACE inhibitors or ARBs: monitor for synergistic blood pressure lowering.